Blackhawk Recevies Correspondance from Health Canada Vancouver, British Columbia – TheNewswire - January 11, 2021 – Blackhawk Growth Corp. (CSE:BLR); (Frankfurt:0JJ); (CNSX:BLR.CN); (OTC:BLRZF) (the “Company”), is pleased to announce that it has received correspondence from Health Canada on Friday, January 8th requesting additional information to be provided for its ExProbe SARS-CoV-2 Testing Kit. Blackhawk is working with the manufacturer and its compliance team to ensure the requested information is provided in short-order. Health Canada has provided a timeline of 10 days to submit the information with the option of a 30-day extension if required.
Blackhawk will continue to update its shareholders as the application process with Health Canada proceeds.
Blackhawk makes no representations or provides any guarantees on Health Canada’s review timelines.
Blackhawk Growth is also excited to announce that the Company has engaged Toronto-based marketing firm North Equities Corp. (“North Equities” or “NE”). The company specializes in various social media platforms, to facilitate greater investor engagement and widespread dissemination of the Company's news as well as generating accessible content showcasing Blackhawk and its initiatives. Through their marketing capabilities on various social media platforms, their intended purpose is to widen the communication outreach while providing up-to-date information about Blackhawk to a much larger audience.
About North Equities
The North Equities team has more than 100 team-years of equity experience and has helped more than 200 companies acquire more than 120k+ investors combined. With the perfect combination of expertise, tactics, and a track record in fundraising and marketing, North Equities has created the next evolution of investor engagement and marketing.
For further information please contact:
Frederick Pels, Chief Executive Officer
(403)-991-7737
fred@blackhawkgrowth.com